Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,500.00
(
-0.93%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
2.39%
)
Bitcoin
70,478.00
(
0.83%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3206
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: DewDiligence post# 126889

Tuesday, 09/20/2011 7:13:24 AM

Tuesday, September 20, 2011 7:13:24 AM

Post# of 257264
MNTA prospects are terrific if they get a timely generic Copaxone approval. If not, then I would think there are many biotechs with better prospects. There's an opportunity cost if it takes a lot longer than you may expect.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today